VolitionRx Limited
VNRX
$1.22
-$0.01-0.81%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 985.10K | 447.00K | 627.30K | 406.70K | 246.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 985.10K | 447.00K | 627.30K | 406.70K | 246.40K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 985.10K | 447.00K | 627.30K | 406.70K | 246.40K |
| SG&A Expenses | 3.48M | 2.80M | 3.44M | 3.98M | 3.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.33M | 5.27M | 5.73M | 6.70M | 5.77M |
| Operating Income | -5.35M | -4.82M | -5.10M | -6.30M | -5.52M |
| Income Before Tax | -6.70M | -6.30M | -5.41M | -6.31M | -5.48M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.70M | -6.30M | -5.41M | -6.31M | -5.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 38.80K | 32.00K | 31.40K | 30.00K | 52.90K |
| Net Income | -6.66M | -6.27M | -5.38M | -6.28M | -5.42M |
| EBIT | -5.35M | -4.82M | -5.10M | -6.30M | -5.52M |
| EBITDA | -5.14M | -4.59M | -4.85M | -6.05M | -5.27M |
| EPS Basic | -0.97 | -1.04 | -0.99 | -1.22 | -1.12 |
| Normalized Basic EPS | -0.51 | -0.65 | -0.62 | -0.76 | -0.70 |
| EPS Diluted | -0.97 | -1.04 | -0.99 | -1.22 | -1.12 |
| Normalized Diluted EPS | -0.51 | -0.65 | -0.62 | -0.76 | -0.70 |
| Average Basic Shares Outstanding | 6.88M | 6.05M | 5.41M | 5.13M | 4.83M |
| Average Diluted Shares Outstanding | 6.88M | 6.05M | 5.41M | 5.13M | 4.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |